Back to LLY
Ensign Peak Advisors, Inc → LLY
Ensign Peak Advisors, Inc LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
7
Latest value
$968.9M
Q3 2026
Peak value
$1.1B
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $478.4M |
| Q4 2025 | $900.2M |
| Q4 2025 | $900.2M |
| Q1 2026 | $780.2M |
| Q1 2026 | $780.2M |
| Q2 2026 | $1.1B |
| Q3 2026 | $968.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $968.9M | 837.4K | — | — |
| Q2 2026 | $1.1B | 895.3K | — | — |
| Q1 2026 | $780.2M | 848.2K | — | — |
| Q1 2026 | $780.2M | 848.2K | — | — |
| Q4 2025 | $900.2M | 837.7K | — | — |
| Q4 2025 | $900.2M | 837.7K | — | — |
| Q3 2025 | $478.4M | 627.0K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B